These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1980197)

  • 1. Maternally administered esmolol decreases fetal as well as maternal heart rate.
    Larson CP; Shuer LM; Cohen SE
    J Clin Anesth; 1990; 2(6):427-9. PubMed ID: 1980197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternally administered esmolol produces fetal beta-adrenergic blockade and hypoxemia in sheep.
    Eisenach JC; Castro MI
    Anesthesiology; 1989 Nov; 71(5):718-22. PubMed ID: 2573294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of fetal heart rate to maternal administration of esmolol.
    Losasso TJ; Muzzi DA; Cucchiara RF
    Anesthesiology; 1991 Apr; 74(4):782-4. PubMed ID: 1672581
    [No Abstract]   [Full Text] [Related]  

  • 4. Esmolol for potentiation of nitroprusside-induced hypotension: impact on the cardiovascular, adrenergic, and renin-angiotensin systems in man.
    Edmondson R; Del Valle O; Shah N; Wong G; Dwyer D; Matarazzo D; Thorne A; Coffey C; Bedford R
    Anesth Analg; 1989 Aug; 69(2):202-6. PubMed ID: 2569849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplacental passage and hemodynamic effects of esmolol in the gravid ewe.
    Ostman PL; Chestnut DH; Robillard JE; Weiner CP; Hdez MJ
    Anesthesiology; 1988 Nov; 69(5):738-41. PubMed ID: 2903702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and antiarrhythmic effects of esmolol in children.
    Trippel DL; Wiest DB; Gillette PC
    J Pediatr; 1991 Jul; 119(1 Pt 1):142-7. PubMed ID: 1676729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias.
    Gray RJ; Bateman TM; Czer LS; Conklin CM; Matloff JM
    J Am Coll Cardiol; 1985 Jun; 5(6):1451-6. PubMed ID: 2860148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the dose range for esmolol used in electroconvulsive therapy hemodynamic attenuation.
    Howie MB; Hiestand DC; Zvara DA; Kim PY; McSweeney TD; Coffman JA
    Anesth Analg; 1992 Nov; 75(5):805-10. PubMed ID: 1358003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapericardial beta-adrenergic blockade with esmolol exerts a potent antitachycardic effect without depressing contractility.
    Moreno R; Waxman S; Rowe K; Verrier RL
    J Cardiovasc Pharmacol; 2000 Dec; 36(6):722-7. PubMed ID: 11117371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of esmolol for the induction of deliberate hypotension.
    Ornstein E; Matteo RS; Weinstein JA; Schwartz AE
    J Clin Anesth; 1988; 1(1):31-5. PubMed ID: 2908483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esmolol infusion versus propranolol infusion: effects on heart rate and blood pressure in healthy volunteers.
    Muller MD; Ahmad TA; Vargas Pelaez AF; Proctor DN; Bonavia AS; Luck JC; Maman SR; Ross AJ; Leuenberger UA; McQuillan PM
    J Appl Physiol (1985); 2017 Mar; 122(3):511-519. PubMed ID: 28035016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of esmolol on the ventricular fibrillation threshold.
    Wallis DE; Wedel VA; Scanlon PJ; Euler DE
    Pharmacology; 1988; 36(1):9-15. PubMed ID: 2893394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An enantiomerically pure formulation of esmolol attenuates hypotension and preserves heart rate control in dogs.
    McKee JS; Rabinow BE; Daller JR; Brooks BD; Baumgartner B; Rohatgi P
    Anesthesiology; 2014 Dec; 121(6):1184-93. PubMed ID: 25105423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are all effects of esmolol equally rapid in onset?
    Ornstein E; Young WL; Ostapkovich N; Matteo RS; Diaz J
    Anesth Analg; 1995 Aug; 81(2):297-300. PubMed ID: 7618718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics and onset of action of esmolol in anesthetized dogs.
    Quon CY; Gorczynski RJ
    J Pharmacol Exp Ther; 1986 Jun; 237(3):912-8. PubMed ID: 2872328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia.
    Sung RJ; Blanski L; Kirshenbaum J; MacCosbe P; Turlapaty P; Laddu AR
    J Clin Pharmacol; 1986 Mar; 26(S1):A15-A26. PubMed ID: 2870082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of esmolol (ASL-8052: an ultrashort-acting beta-adrenergic blocking agent) for control of ventricular rate in supraventricular tachycardias.
    Byrd RC; Sung RJ; Marks J; Parmley WW
    J Am Coll Cardiol; 1984 Feb; 3(2 Pt 1):394-9. PubMed ID: 6141193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol.
    Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK
    Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
    Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB
    Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of esmolol, an ultrashort-acting beta blocker.
    Askenazi J; MacCosbe PE; Hoff J; Turlapaty P; Hua TA; Laddu A
    J Clin Pharmacol; 1987 Aug; 27(8):567-73. PubMed ID: 2888793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.